| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
Total
3
tritriacontanoic acid
tritriacontanoic acid is a lipid of Fatty Acyls (FA) class. Tritriacontanoic acid is associated with abnormalities such as hypercholesterolemia, Metabolic syndrome, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Insulin-Dependent and Parkinson Disease. The involved functions are known as Fermentation, Process, Longterm Effects, Pressure- physical agent and Lipid Metabolism. Tritriacontanoic acid often locates in Blood, Tissue fiber and A Fibers. The associated genes with tritriacontanoic acid are STN gene. The related lipids are Total cholesterol and blood lipid.
Cross Reference
Introduction
To understand associated biological information of tritriacontanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tritriacontanoic acid?
tritriacontanoic acid is suspected in hypercholesterolemia, Metabolic syndrome, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Insulin-Dependent, Parkinson Disease and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tritriacontanoic acid
PubChem Associated disorders and diseases
What pathways are associated with tritriacontanoic acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tritriacontanoic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tritriacontanoic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tritriacontanoic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tritriacontanoic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tritriacontanoic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tritriacontanoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Singh B et al. | The release dynamics of model drugs from the psyllium and N-hydroxymethylacrylamide based hydrogels. | 2006 | Int J Pharm | pmid:16844329 |
| Hoffman D | Psyllium: keeping this boon for patients from becoming a bane for providers. | 2006 | J Fam Pract | pmid:16948959 |
| Shrestha S et al. | A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals. | 2006 | J. Nutr. | pmid:16988115 |
| Gillespie BF and Rathbun FJ | Adverse effects of psyllium. | 1992 | CMAJ | pmid:1728348 |
| Singh B | Psyllium as therapeutic and drug delivery agent. | 2007 | Int J Pharm | pmid:17329047 |
| Cybulski KA et al. | The threshold for satiating effectiveness of psyllium in a nutrient base. | 1992 | Physiol. Behav. | pmid:1741454 |
| Petchetti L et al. | Nutriceuticals in cardiovascular disease: psyllium. | Cardiol Rev | pmid:17438377 | |
| Shrestha S et al. | A combination of psyllium and plant sterols alters lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipoproteins and increasing LDL uptake. | 2007 | J. Nutr. | pmid:17449576 |
| Laxative drug products for over-the-counter human use; psyllium ingredients in granular dosage forms. Final rule. | 2007 | Fed Regist | pmid:17450664 | |
| Morehouse H et al. | Addition of Metamucil to gelatin for a realistic breast biopsy phantom. | 2007 | J Ultrasound Med | pmid:17646379 |